DAG1 and neuromuscular disease caused by qualitative or quantitative defects of alpha-dystroglycan: Dystroglycanopathies are a group of muscular dystrophies resulting from abnormal glycosylation of α-dystroglycan (α-DG) that leads to reduced binding affinity for extracellular matrix proteins [1].